Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amitriptyline for headache and sleep disorders in patients with mild stroke
IRCT20230627058603N1Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of amitriptyline in Headache, sleep disorder, traumatic brain injury (TBI) and 1 more, sponsored by Isfahan University of Medical Sciences. Started Aug 2023; status: completed.
02
Drugs
amitriptyline
03
Conditions
Headachesleep disordertraumatic brain injury (TBI)stroke
Beyond the preview
Go deeper on IRCT20230627058603N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230627058603N1.